CANCER GENOMICS CONSORTIUM Trademark

Trademark Overview

On Friday, May 2, 2025, a trademark application was filed for CANCER GENOMICS CONSORTIUM with the United States Patent and Trademark Office. The USPTO has given the CANCER GENOMICS CONSORTIUM trademark a serial number of 99167148. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Wednesday, February 11, 2026. This trademark is owned by Cancer Genomics Consortium. The CANCER GENOMICS CONSORTIUM trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:

Association services, namely, promoting the public interest and awareness in cancer research and education; Promoting public interest and awareness of cancer research.

Providing information about medical research in the field of cancer.
cancer genomics consortium

General Information

Serial Number99167148
Word MarkCANCER GENOMICS CONSORTIUM
Filing DateFriday, May 2, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateWednesday, February 11, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2026

Trademark Statements

Goods and ServicesAssociation services, namely, promoting the public interest and awareness in cancer research and education; Promoting public interest and awareness of cancer research.
NOT AVAILABLE"CONSORTIUM"
Goods and ServicesProviding information about medical research in the field of cancer.

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, May 2, 2025
Primary Code035
First Use Anywhere DateSaturday, August 15, 2015
First Use In Commerce DateSaturday, August 15, 2015
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 2, 2025
Primary Code042
First Use Anywhere DateSaturday, August 15, 2015
First Use In Commerce DateSaturday, August 15, 2015

Trademark Owner History

Party NameCancer Genomics Consortium
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFletcher, NC 28732

Trademark Events

Event DateEvent Description
Friday, May 2, 2025NEW APPLICATION ENTERED
Friday, May 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 2, 2025APPLICATION FILING RECEIPT MAILED
Friday, September 12, 2025ASSIGNED TO EXAMINER
Monday, September 22, 2025ASSIGNED TO EXAMINER
Friday, September 26, 2025NON-FINAL ACTION WRITTEN
Friday, September 26, 2025NON-FINAL ACTION E-MAILED
Friday, September 26, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 2, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 16, 2025REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Tuesday, December 16, 2025NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Tuesday, December 16, 2025NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Monday, December 29, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 6, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 6, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 6, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 6, 2026TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 13, 2026TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 13, 2026CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 13, 2026TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 6, 2026EXAMINERS AMENDMENT -WRITTEN
Friday, February 6, 2026EXAMINERS AMENDMENT E-MAILED
Friday, February 6, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, February 6, 2026EXAMINER'S AMENDMENT ENTERED
Friday, February 6, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

consortium genomics cancer research awareness public interest promoting about medical field information